Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Impairment of Nitric Oxide Pathway by Intravascular Hemolysis Plays a Major Role in Mice Esophageal Hypercontractility: Reversion by Soluble Guanylyl Cyclase Stimulator

Full text
Silva, Fabio Henrique [1] ; Fertrin, Kleber Yotsumoto [1, 2] ; Alexandre, Eduardo Costa [3] ; Calmasini, Fabiano Beraldi [3] ; Franco-Penteado, Carla Fernanda [1] ; Costa, Fernando Ferreira [1]
Total Authors: 6
[1] Univ Estadual Campinas, Fac Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP - Brazil
[2] Univ Washington, Div Hematol, Seattle, WA 98195 - USA
[3] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: Journal of Pharmacology and Experimental Therapeutics; v. 367, n. 2, p. 194-202, NOV 1 2018.
Web of Science Citations: 1

Paroxysmal nocturnal hemoglobinuria (PNH) patients display exaggerated intravascular hemolysis and esophageal disorders. Since excess hemoglobin in the plasma causes reduced nitric oxide (NO) bioavailability and oxidative stress, we hypothesized that esophageal contraction may be impaired by intravascular hemolysis. This study aimed to analyze the alterations of the esophagus contractile mechanisms in a murine model of exaggerated intravascular hemolysis induced by phenylhydrazine (PHZ). For comparative purposes, sickle cell disease (SCD) mice were also studied, a less severe intravascular hemolysis model. Esophagus rings were dissected free and placed in organ baths. Plasma hemoglobin was higher in PHZ compared with SCD mice, as expected. The contractile responses produced by carbachol (CCh), KCl, and electrical-field stimulation (EFS) were superior in PHZ esophagi compared with control but remained unchanged in SCD mice. Preincubation with the NO-independent soluble guanylate cyclase stimulator 3-(4-amino-5-cyclopropylpyrimidin-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo{[ }3,4-b] pyridine (BAY 41-2272; 1 mu M) completely reversed the increased contractile responses to CCh, KCl, and EFS in PHZ mice, but responses remained unchanged with prior treatment with NO donor sodium nitroprusside (300 mu M). Protein expression of 3-nitrotyrosine and 4-hydroxynonenal increased in esophagi from PHZ mice, suggesting a state of oxidative stress. In endothelial nitric oxide synthase gene-deficient mice, the contractile responses elicited by KCl and CCh were increased in the esophagus but remained unchanged with the intravascular hemolysis induced by PHZ. In conclusion, our results show that esophagus hypercontractile state occurs in association with lower NO bioavailability due to exaggerated hemolysis intravascular and oxidative stress. Moreover, our study supports the hypothesis that esophageal disorders in PNH patients are secondary to intravascular hemolysis affecting the NO-cGMP pathway. (AU)

FAPESP's process: 17/08122-9 - Priapism and voiding dysfunction in Sickle Cell Disease: pathophysiology and new drug candidates
Grantee:Fábio Henrique da Silva
Support type: Research Grants - Young Investigators Grants
FAPESP's process: 18/06243-6 - Priapism and voiding dysfunction in sickle cell disease: pathophysiology and new drug candidates
Grantee:Fábio Henrique da Silva
Support type: Scholarships in Brazil - Young Researchers
FAPESP's process: 14/00984-3 - Red blood cell disorders: pathophysiology and new therapeutic approaches
Grantee:Fernando Ferreira Costa
Support type: Research Projects - Thematic Grants